Commodore Capital
SURF

Commodore Capital’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Commodore Capital’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-467,796
Closed -$4.32M – 35
2020
Q4 		$4.32M Buy
+467,796
New +$4.07M 2.35% 20

Other funds holding SURF

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.5B AUM 50.54% 1-Year Est. Return
Atlas Venture Associates IX
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Commodore Capital's SURF Position: Q1 2021 in Review

Commodore Capital sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2021, closing a stake of 467,796 shares — an estimated $4.32M sold.

Commodore Capital first reported a position in SURF in Q4 2020 and held it in 1 quarter. The position peaked at $4.32M in Q4 2020. 90 funds tracked by Wall St. Rank hold SURF as of Q1 2021.

  • Commodore Capital reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Commodore Capital sold 467,796 Surface Oncology, Inc. Common Stock shares in Q1 2021, an estimated $4.32M.
  • Commodore Capital first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Commodore Capital's Surface Oncology, Inc. Common Stock position peaked at $4.32M in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2021.

Based on Commodore Capital's 13F filing for Q1 2021, filed 17 May 2021.